Business

NSB Receives A$2.2M Research & Development Tax Refund

NSB Receives A$2.2M Research & Development Tax Refund

Neuroscientific Biopharmaceuticals Ltd.March 19, 20244
NSB Receives A$2.2M Research & Development Tax Refund

About this update from Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd has released a press release. View Attachment

View stock analysis, news, and events for Neuroscientific Biopharmaceuticals Ltd.

More from Neuroscientific Biopharmaceuticals Ltd.

All Neuroscientific Biopharmaceuticals Ltd. news →